NL8002094A - Diagnostische methode. - Google Patents

Diagnostische methode. Download PDF

Info

Publication number
NL8002094A
NL8002094A NL8002094A NL8002094A NL8002094A NL 8002094 A NL8002094 A NL 8002094A NL 8002094 A NL8002094 A NL 8002094A NL 8002094 A NL8002094 A NL 8002094A NL 8002094 A NL8002094 A NL 8002094A
Authority
NL
Netherlands
Prior art keywords
cancer
concentration
protein
value
serum
Prior art date
Application number
NL8002094A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8002094A publication Critical patent/NL8002094A/nl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8002094A 1979-04-10 1980-04-09 Diagnostische methode. NL8002094A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10
US2873279 1979-04-10

Publications (1)

Publication Number Publication Date
NL8002094A true NL8002094A (nl) 1980-10-14

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8002094A NL8002094A (nl) 1979-04-10 1980-04-09 Diagnostische methode.

Country Status (24)

Country Link
JP (1) JPS55143441A (fi)
KR (1) KR830002502A (fi)
AR (1) AR222700A1 (fi)
AT (1) AT365343B (fi)
AU (1) AU536522B2 (fi)
BE (1) BE882669A (fi)
CH (1) CH644453A5 (fi)
DE (1) DE3013837A1 (fi)
DK (1) DK149980A (fi)
ES (1) ES490396A0 (fi)
FI (1) FI801078A (fi)
FR (1) FR2454099A1 (fi)
GB (1) GB2047712B (fi)
GR (1) GR67692B (fi)
HU (1) HU183122B (fi)
IE (1) IE49981B1 (fi)
IL (1) IL59772A (fi)
IT (1) IT1143135B (fi)
LU (1) LU82345A1 (fi)
NL (1) NL8002094A (fi)
NO (1) NO801018L (fi)
PH (1) PH15637A (fi)
SE (1) SE8002602L (fi)
ZA (1) ZA802141B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
IT1143135B (it) 1986-10-22
AU536522B2 (en) 1984-05-10
IL59772A0 (en) 1980-06-30
DK149980A (da) 1980-10-11
KR830002502A (ko) 1983-05-30
IE49981B1 (en) 1986-01-22
BE882669A (fr) 1980-10-06
ES8103380A1 (es) 1981-02-16
FR2454099A1 (fr) 1980-11-07
CH644453A5 (fr) 1984-07-31
NO801018L (no) 1980-10-13
FI801078A (fi) 1980-10-11
IT8048370A0 (it) 1980-04-09
IL59772A (en) 1983-05-15
AR222700A1 (es) 1981-06-15
FR2454099B1 (fi) 1984-01-27
AT365343B (de) 1982-01-11
GR67692B (fi) 1981-09-07
PH15637A (en) 1983-03-11
AU5719380A (en) 1980-10-16
GB2047712A (en) 1980-12-03
ATA195780A (de) 1981-05-15
HU183122B (en) 1984-04-28
DE3013837A1 (de) 1980-10-30
LU82345A1 (fr) 1980-12-16
IE800693L (en) 1980-10-10
GB2047712B (en) 1983-02-23
SE8002602L (sv) 1980-12-09
ZA802141B (en) 1981-04-29
JPS55143441A (en) 1980-11-08
ES490396A0 (es) 1981-02-16

Similar Documents

Publication Publication Date Title
Poh-Fitzpatrick et al. Direct spectrofluorometry of diluted erythrocytes and plasma: a rapid diagnostic method in primary and secondary porphyrinemias
Hastka et al. Washing erythrocytes to remove interferents in measurements of zinc protoporphyrin by front-face hematofluorometry
Payne et al. Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual.
Buzanovskii Determination of proteins in blood. Part 1: determination of total protein and albumin
Gordon et al. Analysis of serum cancer procoagulant activity and its possible use as a tumor marker
Sonnenblick et al. Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma.
Heller et al. A simplified assay for porphyrins in whole blood
HU188057B (en) Analytical process based on reaction of antigene-antibody and reagent for the process
US4270924A (en) Diagnostic method for detecting cancer
Gelderman et al. Lactic dehydrogenase isozymes in urine from patients with malignancies of the urinary bladder
Wojcik et al. Human epididymis protein 4 (HE4) in patients with small-cell lung cancer
Schwartz et al. Quantitative assay of erythrocyte “free” and zinc-protoporphyrin: Clinical and genetic studies
NL8002094A (nl) Diagnostische methode.
US5260186A (en) Provision of density specific blood cells for the structuredness of the cytoplasmic matrix (SCM) test
Glen Measurement of DNA and RNA in human peripheral blood lymphocytes
Buffone et al. Characterization and evaluation of immunochemical methods for the measurement of fecal α 1-antitrypsin
Fernandez et al. A preliminary study of urinary transferrin as a marker for prostatic cancer
US4424278A (en) Cancer detection procedure using an acyl carrier protein
Colleen et al. Carcinoembryonic Antigen in Urine in Patients with Urothelial Carcinoma: An Expression for the Extent of Inflammatory Reaction of the Urinary Tract
JP2553606B2 (ja) 密度特異血球の分離及び使用方法
US3476514A (en) Cancer cytoscreening
Anh-Tuan et al. Detection and quantitation of hepatitis B surface antigen immune complexes (HBsAg-ICs) by an antigen-specific method. II. Circulating immune complexes (CICs) in patients with hepatitis B and asymptomatic HBsAg carriers
CA2232004C (en) Method for screening for prostate cancer by measuring apolipoprotein d levels in body fluid
deVere White et al. Predicting the invasive potential of bladder carcinoma
Schleich et al. Ovarian carcinoma: Increase in clinical validity by simultaneous determination of SRA and CA 125

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: BAYLOR COLLEGE OF MEDICINE

A85 Still pending on 85-01-01
BV The patent application has lapsed